Navigation Links
The brain loves a surprise

Scientists in Atlanta, Georgia, have opined after an exhaustive study that the brain loves a surprise. The study was conducted on 25 men and women and studied their responses to different stimuli. Dr. Gregory S Berns of Emory University led the study. The fact that some people rely on an orderly routine, while others thrive on never knowing what the day will bring, may have something to do with the brain's "pleasure centers," researchers have found.

In the study, Berns and his colleagues gave the participants drops of water and fruit juice. Part of the time, the sequence of water and juice drops was predictable, while at other points the sequence varied.

It was at this time of unpredictability that the researchers noticed marked stimulation in the brain's pleasure centers in many, but not all, of the participants. Although this study could not delve into why a surprise dash of juice or water would stimulate the brain, Berns speculated that the activity in the brain's pleasure centers is linked to people's personalities.

For instance, a person who craves twists and turns in life might show greater activity in response to a pleasant surprise than would a person who needs consistency.

Being alert to out-of-the-ordinary conditions, Dr. Berns noted, is important to survival.

So the next time you give someone a pleasant surprise, rest assured their brains would love you!!!

'"/>




Page: 1

Related medicine news :

1. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
2. Two doctors suspended for wrong brain surgery
3. Increase in sugar...decrease in brain function!!!
4. Alcohol shrinks brain
5. Roller coaster takes brain for a big ride!!
6. The big brain in suicides
7. Stuttering and brain anatomy
8. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
9. Alcohol linked to brain activity
10. Drug abuse leads to long standing changes in the brain
11. Detecting brain aneurysms
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The brain loves surprise

(Date:5/16/2008)...ould report side effects, but critics want agency ...6 (HealthDay News) -- Direct-to-consumer drug ads ...ber that would allow consumers to report adverse s... , The experts serve on a panel that advises th...mbers are already mandated by the FDA for print ad...
(Date:5/16/2008)...from an international, multicenter Phase III clini... therapy everolimus (RAD001) significantly delays ...ney cancer whose disease had worsened on other tre...an attending physician at Memorial Sloan-Kettering...ngs on May 31 at the annual meeting of the America...
(Date:5/16/2008)...o Save Vital Services for Frail Seniors and People...wswire-USNewswire/ -- Thousands of,homecare worker...warzenegger,s proposed cuts to hours of service, w...ornia,s most vulnerable workers and the,people the...these vital,services for seniors and people with d...
(Date:5/16/2008)... country needs is more unemployed politicians - an...FirstCall/ -- Although nearly all,voters place hea...s" list,a looming federal budgetary crunch means ...he current presidential candidates is likely to be...ority Leader Bill Frist., Jousting with Princeton...
Breaking Medicine News(10 mins):Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3Health News:Drug fends off kidney cancer progression 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3
...in American women found that most of them had insu...ntal and physical health// , personal lives, profe...urvey sponsored by the National Sleep Foundation, ...s 18 t0 65 spread all over America and found that ...
Diminishing Differences and Empowering Eves
...nd HIV positive during 2006 and, among them, over ...thers// who were either suffering from full-blown ...as said. Epidemiologist Guennadi Onitshenko said ... born of AIDS carrier parents have not developed s...
... injured at least 35 people who need medical treat...erate// quake measuring 4.8 on Richter scale hit I...of the quake, which occurred at 2 a.m., was atDaro...d an official of the city governor's office. The ...
Other Medicine News:Health News:Sleep Problems of Women 2Health News:Diminishing Differences and Empowering Eves 2Health News:Diminishing Differences and Empowering Eves 3
(Date:5/15/2008)... ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/...hat it has completed enrollment in the Phase I/IIa... a total of approximately,230 subjects. Favorable ...,which included dose-escalation in 70 healthy adul...interim findings suggested that the vaccine,is wel...
(Date:5/15/2008)... Medicare Advantage Fee-For-Service Plan Positions...w Business, According to a New Report from ...LE, Tenn., May 15 /- HealthLeaders-In...ket intelligence, reports that as the,economy cont...eld of,Michigan remains the best equipped of all o...
(Date:5/15/2008)... Randomized TRIAS HR Pilot Study Compares Geno... Taxus(R), Other Presentations Focus on Real-W...ts with AMI, Those Who Could Not Tolerate Dual-Ant... BARCELONA, Spain, May 15 /- OrbusNei...sentations in a symposium at EuroPCR 2008,support ...
(Date:5/15/2008)... GREEN BAY, Wis., May 15 /- Omega...be further considered as a credible natural,altern...y in ADHD patients,recent in vivo French study re...ial effects of omega-3 in hyperactivity, French re...d have specific positive effects on,impulse contro...
Breaking Medicine Technology:Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3New Computerized Scans Effective for Spotting Clogged Arteries 5516 1New Computerized Scans Effective for Spotting Clogged Arteries 5516 2New Computerized Scans Effective for Spotting Clogged Arteries 5516 3Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 1Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 2Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 3Baxter Kidney Patient Education Program Celebrates Tenth Anniversary 1687 4Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 1Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 2Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 3Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 4Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 5Keryx Biopharmaceuticals Inc Announces Positive Preliminary Phase 2 Data on KRX 0401 in Patients with Chemo Insensitive Rare Sarcoma 752 6Progen Presents Additional Analysis of Data from PI 88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 749 1Progen Presents Additional Analysis of Data from PI 88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 749 2Progen Presents Additional Analysis of Data from PI 88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 749 3
The latest from the leader in automatic slide stainers. It offers a truly unique and modern approach to slide staining, ending messy procedures. The instrument of choice for peripheral blood smears,
Cholesterol single reagent. Storage temp: 2 - 8 C. Linearity: 0 - 600 mg. Expected values: Recommended 240 mg/dL. Available with calibrator and performed 500 number of test.
For the quantitative determination of total cholesterol in serum.
Intended for the quantitative determination of total cholesterol in serum. Reaction: Endpoint. Reaction complete within five minutes. Wavelength: 500 nm. Linearity: 700 mg/dL (18.1 mmol/L). Single st
Medicine Products: